University of Chicago’s Pyxis Oncology PYXS Stock Holding History

University of Chicago’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71.1K	Hold	48,731	–	–	0.02%	13
2025 Q4	$56K	Hold	48,731	–	–	0.03%	12
2025 Q3	$108K	Hold	48,731	–	–	0.05%	11
2025 Q2	$53.6K	Hold	48,731	–	–	0.05%	11
2025 Q1	$47.8K	Hold	48,731	–	–	0.07%	12
2024 Q4	$76K	Hold	48,731	–	–	0.07%	5
2024 Q3	$179K	Hold	48,731	–	–	0.15%	5
2024 Q2	$161K	Hold	48,731	–	–	0.12%	7
2024 Q1	$208K	Hold	48,731	–	–	0.3%	6
2023 Q4	$87.7K	Hold	48,731	–	–	0.12%	8
2023 Q3	$97K	Hold	48,731	–	–	0.06%	6
2023 Q2	$125K	Hold	48,731	–	–	0.06%	6
2023 Q1	$195K	Hold	48,731	–	–	0.09%	5
2022 Q4	$65.3K	Buy	+48,731	New	+$73.1K	0.05%	5

Other funds holding PYXS

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GGI

GordonMD Global Investments Beverely Hills, California $144M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

University of Chicago's PYXS Position: Q1 2026 in Review

University of Chicago held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 48,731 shares worth $71.1K. The position accounts for 0.02% of the portfolio, ranked #13.

University of Chicago first reported a position in PYXS in Q4 2022 and has held it in 14 quarters since. The position peaked at $208K in Q1 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

University of Chicago held 48,731 shares of Pyxis Oncology worth $71.1K as of Q1 2026.
University of Chicago left its Pyxis Oncology share count unchanged in Q1 2026.
Pyxis Oncology made up 0.02% of University of Chicago's portfolio in Q1 2026, its #13 holding.
University of Chicago first reported a position in Pyxis Oncology in Q4 2022 and has held it in 14 quarters since.
University of Chicago's Pyxis Oncology position peaked at $208K in Q1 2024.
78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on University of Chicago's 13F filing for Q1 2026, filed 7 May 2026.